Q5125 Inj, releuko 1 mcg

Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 1800 units per day (practitioner), rationale: Prescribing Information